Stock EDSA EDESA BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Edesa Biotech, Inc.

Equities

EDSA

CA27966L3065

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
4.26 USD +0.24% Intraday chart for Edesa Biotech, Inc. -0.85% -6.78%
Jun. 24 BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS CI
May. 10 Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI

Evolution of the average Target Price on Edesa Biotech, Inc.

Price target over the last 5 years

History of analyst recommendation changes

072012ae1e98647f3628c1cf9261c5.3Ul-uXoBfkEoPWMAxOaygkjHkdoCwd_XGJJ3rBsS98Y.rTwP0R5FBzVgTyZtl8vasg-g-7NXk6-HWs0-mU9zgPDoC0_oGzMNNUdkCA~54cfb8583e7976f385567f4b12a914ed

Analyst Recommendations on Edesa Biotech, Inc.

HC Wainwright Adjusts Price Target on Edesa Biotech to $21 From $70, Keeps Buy Rating MT
HC Wainwright Adjusts Edesa Biotech Price Target to $10 From $16, Maintains Buy Rating MT
HC Wainwright Starts Edesa Biotech at Buy With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.26 USD
Average target price
20.5 USD
Spread / Average Target
+381.22%
High Price Target
21 USD
Spread / Highest target
+392.96%
Low Price Target
20 USD
Spread / Lowest Target
+369.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Edesa Biotech, Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EDSA Stock
  4. Consensus Edesa Biotech, Inc.